2HE Stock Overview Provides technology-enabled services platforms to consumers and employers in the United States. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
HealthEquity, Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for HealthEquity Historical stock prices Current Share Price US$101.00 52 Week High US$101.00 52 Week Low US$62.50 Beta 0.54 1 Month Change 10.99% 3 Month Change 25.47% 1 Year Change 47.45% 3 Year Change 122.03% 5 Year Change 55.38% Change since IPO 682.95%
Recent News & Updates
HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2025 and Fiscal Year Ending January 31, 2026 Dec 10
HealthEquity, Inc. and WageWorks, Inc. Settle Their Lawsuit with Union Mesa 1, LLC Dec 01
HealthEquity, Inc. and WageWorks, Inc. Settle Their Lawsuit with Union Mesa 1, LLC Nov 30 HealthEquity, Inc. Announces CEO Changes, Effective January 6, 2025
HealthEquity, Inc. to Report Q3, 2025 Results on Dec 09, 2024 Oct 31 HealthEquity, Inc Launches HSAnswers Oct 15
See more updates
HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2025 and Fiscal Year Ending January 31, 2026 Dec 10
HealthEquity, Inc. and WageWorks, Inc. Settle Their Lawsuit with Union Mesa 1, LLC Dec 01
HealthEquity, Inc. and WageWorks, Inc. Settle Their Lawsuit with Union Mesa 1, LLC Nov 30 HealthEquity, Inc. Announces CEO Changes, Effective January 6, 2025
HealthEquity, Inc. to Report Q3, 2025 Results on Dec 09, 2024 Oct 31 HealthEquity, Inc Launches HSAnswers Oct 15
Executive VP & CTO recently sold €853k worth of stock Sep 11
Second quarter 2025 earnings released: EPS: US$0.41 (vs US$0.12 in 2Q 2024) Sep 04 HealthEquity, Inc. (NasdaqGS:HQY) announces an Equity Buyback for $300 million worth of its shares.
HealthEquity, Inc. to Report Q2, 2025 Results on Sep 03, 2024 Aug 14
HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2025 Jun 05
First quarter 2025 earnings released: EPS: US$0.33 (vs US$0.048 in 1Q 2024) Jun 04
HealthEquity, Inc. to Report Q1, 2025 Results on Jun 03, 2024 May 09
HealthEquity, Inc., Annual General Meeting, Jun 27, 2024 Apr 28
Full year 2024 earnings released: EPS: US$0.65 (vs US$0.31 loss in FY 2023) Mar 20
HealthEquity, Inc. to Report Q4, 2024 Results on Mar 19, 2024 Mar 06
HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ended January 31, 2024 and Fiscal Year Ending January 31, 2025 Feb 22
Third quarter 2024 earnings released: EPS: US$0.17 (vs US$0.019 loss in 3Q 2023) Dec 07
HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2024 and 2025 Dec 06
HealthEquity, Inc. to Report Q3, 2024 Results on Dec 05, 2023 Nov 09
HealthEquity, Inc. (NasdaqGS:HQY) entered into a definitive agreement to acquire BenefitWallet’s Health Savings Account (HSA) portfolio from Conduent Business Services, LLC for $425 million. Sep 20
Now 21% undervalued Sep 11
HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2024 Sep 07
Second quarter 2024 earnings released: EPS: US$0.12 (vs US$0.13 loss in 2Q 2023) Sep 06
HealthEquity, Inc. to Report Q2, 2024 Results on Sep 05, 2023 Aug 09
HealthEquity, Inc. Announces the Termination of the Employment of Larry Trittschuh, Executive Vice President and Chief Security Officer Jul 29
Executive VP & CTO recently sold €607k worth of stock Jun 16 HealthEquity, Inc. Announces Change of CFO
First quarter 2024 earnings released: EPS: US$0.048 (vs US$0.16 loss in 1Q 2023) Jun 06
HealthEquity, Inc. Provides Earnings Guidance for the Year Ending January 31, 2024 Jun 06
HealthEquity, Inc. to Report Q1, 2024 Results on Jun 05, 2023 May 09
Full year 2023 earnings released: US$0.31 loss per share (vs US$0.53 loss in FY 2022) Mar 22
Now 22% undervalued after recent price drop Mar 14
Independent Director recently sold €305k worth of stock Dec 18
HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2023 and January 31, 2024 Dec 09
Third quarter 2023 earnings released: US$0.019 loss per share (vs US$0.06 loss in 3Q 2022) Dec 07
HealthEquity, Inc. to Report Q3, 2023 Results on Dec 06, 2022 Nov 16
Independent Director recently sold €312k worth of stock Oct 01
Independent Director recently sold €1.8m worth of stock Sep 24
Second quarter 2023 earnings released: US$0.13 loss per share (vs US$0.046 loss in 2Q 2022) Sep 07
HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2023 Sep 07
Healthequity, Inc. Elects Paul M. Black to Board of Directors and to Audit and Risk Committee and Talent, Compensation and Culture Committee Sep 02
HealthEquity, Inc. to Report Q2, 2023 Results on Sep 06, 2022 Aug 10
HealthEquity, Inc. Announces Executive Changes Aug 03
First quarter 2023 earnings released: US$0.16 loss per share (vs US$0.032 loss in 1Q 2022) Jun 08
HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2023 Jun 07
HealthEquity, Inc. to Report Q1, 2023 Results on Jun 06, 2022 May 17
HealthEquity, Inc., Annual General Meeting, Jun 23, 2022 May 14
HealthEquity, Inc. Expands Board of Directors May 04
Insufficient new directors Apr 27
HealthEquity, Inc. to Report Q4, 2022 Results on Mar 22, 2022 Mar 03
HealthEquity, Inc. Provides Revenue Guidance for the Fiscal Year 2023 Feb 24
Independent Director recently bought €949k worth of stock Dec 11
HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2022 Dec 09
Third quarter 2022 earnings: EPS in line with expectations, revenues disappoint Dec 07
Independent Director recently sold €462k worth of stock Oct 09
HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2022 Sep 10
Second quarter 2022 earnings released: EPS US$0.56 (vs US$0.002 loss in 2Q 2021) Sep 09
Executive Vice President of Sales William Otten has left the company Aug 19
Independent Director recently sold €647k worth of stock Jul 20
Independent Director recently sold €290k worth of stock Jun 26
Healthequity, Inc. Revises Earnings Guidance for the Fiscal Year Ending January 31, 2022 Jun 09
HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2022 Jun 08
First quarter 2022 earnings released: US$0.032 loss per share (vs US$0.026 profit in 1Q 2021) Jun 08
HealthEquity, Inc. (NasdaqGS:HQY) entered into a Custodial Transfer and Asset Purchase Agreement to acquire Health Savings Account Business of Fifth Third Bancorp from Fifth Third Bank, National Association for $60.8 million. Apr 28
Full year 2021 earnings released: EPS US$0.12 (vs US$0.59 in FY 2020) Apr 02
Full year 2021 earnings released: EPS US$0.12 (vs US$0.59 in FY 2020) Mar 17
HealthEquity, Inc. (NasdaqGS:HQY) acquired Luum from Evan McCordick for $67.2 million. Mar 10
HealthEquity, Inc. to Report Q4, 2021 Results on Mar 15, 2021 Feb 24
HealthEquity, Inc. has completed a Follow-on Equity Offering in the amount of $401.5 million. Feb 18
New 90-day high: €64.00 Jan 15
Independent Director recently sold €202k worth of stock Jan 13
Executive Vice President of Sales recently sold €103k worth of stock Dec 14
Revenue beats expectations Dec 08
Third quarter 2021 earnings released: EPS US$0.023 Dec 08
Healthequity, Inc. Appoints Stuart Parker as A Member of the Board Dec 06
HealthEquity, Inc. to Report Q3, 2021 Results on Dec 07, 2020 Nov 17
New 90-day high: €53.50 Nov 11
New 90-day low: €42.60 Sep 17
First half earnings released Sep 11
HealthEquity, Inc. to Report Q2, 2021 Results on Sep 08, 2020 Aug 12
HealthEquity, Inc. has completed a Follow-on Equity Offering in the amount of $257.6 million. Jul 09
HealthEquity, Inc.(NasdaqGS:HQY) dropped from Russell 2000 Growth-Defensive Index Jul 05 Shareholder Returns 2HE DE Healthcare DE Market 7D 1.0% 0.9% 2.3% 1Y 47.4% 28.7% 11.9%
See full shareholder returns
Return vs Market: 2HE exceeded the German Market which returned 13.2% over the past year.
Price Volatility Is 2HE's price volatile compared to industry and market? 2HE volatility 2HE Average Weekly Movement 5.5% Healthcare Industry Average Movement 4.8% Market Average Movement 4.8% 10% most volatile stocks in DE Market 10.8% 10% least volatile stocks in DE Market 2.4%
Stable Share Price: 2HE has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 2HE's weekly volatility (6%) has been stable over the past year.
About the Company HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool.
Show more HealthEquity, Inc. Fundamentals Summary How do HealthEquity's earnings and revenue compare to its market cap? 2HE fundamental statistics Market cap €8.72b Earnings (TTM ) €92.86m Revenue (TTM ) €1.10b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 2HE income statement (TTM ) Revenue US$1.15b Cost of Revenue US$398.81m Gross Profit US$751.54m Other Expenses US$654.83m Earnings US$96.70m
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/01/22 12:25 End of Day Share Price 2025/01/22 00:00 Earnings 2024/10/31 Annual Earnings 2024/01/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources HealthEquity, Inc. is covered by 24 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Mark Marcon Baird Ishan Majumdar Baptista Research Alexander Paris Barrington Research Associates, Inc.
Show 21 more analysts 
